Last reviewed · How we verify

NCT04165681

A Mobile and Virtual Reality Intervention for Adolescent Depression

Completed NA Last updated 7 July 2020
What this trial tests

NA trial testing Limbix Spark in Depression in 30 participants. Completed in 17 April 2020.

Timeline
12 October 2019
Primary endpoint
19 March 2020
17 April 2020

Quick facts

Lead sponsorLimbix Health, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment30
Start date12 October 2019
Primary completion19 March 2020
Estimated completion17 April 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Limbix Health, Inc.

Who can join

Adults 12 to 21, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Depression, the most common mental health disorder among adolescents, is a critical health problem within the US. In this study, the feasibility, acceptability, and preliminary efficacy of Limbix Spark, a cognitive behavioral therapy (CBT)- based mobile app + virtual reality (VR) program for helping adolescents live well with depression will be investigated. This program is specifically designed around behavioral activation theory, the idea that completing activities that make a patient feel pleasure or provide a sense of mastery are effective in reducing symptoms of depression. The program involves the use of both VR and a mobile app that include CBT components like psychological assessments, psychoeducation, and skills training. 30 participants aged 12-21 years old with mild to severe depressive symptoms and smartphone access will be enrolled in this study. The primary efficacy outcome measures will be depressive symptoms with anxiety symptoms, functional outcomes, and dimensional scales of positive and negative affect and behavioral activation serving as secondary outcome measures. Qualitative and quantitative feedback on the use of the VR + mobile app (ease of use, comfort, willingness to use again) will be assessed using questionnaires. Engagement and adherence to the program will be assessed by assessing VR and app usage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Self-Guided Digital Intervention for Depression in Adolescents: Feasibility and Preliminary Efficacy Study.
    Miller I, Peake E, Strauss G, Vierra E, et al · · 2023 · cited 10× · PMID 37991839 · DOI 10.2196/43260

Verify or expand the search:

Other trials of Limbix Spark

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Limbix Health, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04165681.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing